Diagnostic performance of 18F-fluciclovine PET/CT for regional lymph node metastases in patients with primary prostate cancer: a multicenter phase II clinical trial-Reference-Cited by-同舟云学术

Diagnostic performance of 18F-fluciclovine PET/CT for regional lymph node metastases in patients with primary prostate cancer: a multicenter phase II clinical trial

Published:2019-05-16 Issue:9 Volume:49 Page:803-811
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Suzuki Hiroyoshi¹,Jinnouchi Seishi²,Kaji Yasushi³,Kishida Takeshi⁴,Kinoshita Hidefumi⁵,Yamaguchi Seiji⁶,Tobe Toyofusa⁷,Okamura Takehiko⁸,Kawakita Mutsushi⁹,Furukawa Junya¹⁰,Otaka Akiharu¹¹,Kakehi Yoshiyuki¹²

Affiliation:

1. Department of Urology, Toho University Sakura Medical Center, Sakura, Japan

2. Atsuchi Memorial Clinic PET Center, Kagoshima, Japan

3. Department of Radiology, Dokkyo Medical University, Shimotuga-gun, Japan

4. Department of Urology, Kanagawa Cancer Center, Yokohama, Japan

5. Department of Urology and Andrology, Kansai Medical University, Hirakata, Japan

6. Department of Urology, Osaka General Medical Center, Osaka, Japan

7. Department of Urology, Saiseikai Utsunomiya Hospital, Utsunomiya, Japan

8. Department of Urology, Anjo Kosei Hospital, Anjo, Japan

9. Department of Urology, Kobe City Medical Center General Hospital, Kobe, Japan

10. Division of Urology, Department of Surgery Related, Kobe University Graduate School of Medicine, Kobe, Japan

11. Clinical Development Department, Nihon Medi-Physics Co., Ltd, Koto-ku, Japan

12. Department of Urology, Kagawa University Faculty of Medicine, Kita-gun, Kagawa, Japan

Abstract

18F-fluciclovine PET/CT was evaluated in the diagnosis of lymph node metastases. Of 40 lymph nodes, metastasis was confirmed by pathology in seven, and four were positive for metastasis by 18F-fluciclovine.

Funder

Nihon Medi-Physics Co., Ltd.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/49/9/803/30150603/hyz072.pdf

Reference31 articles.

1. Evidenced-based clinical practice guideline for prostate cancer (summary: Japanese Urological Association, 2016 edition);Kakehi;Int J Urol,2017

2. Lymph node size does not correlate with the presence of prostate cancer metastasis;Tiguert;Urology,1999

3. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis;Hövels;Clin Radiol,2008

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature;European Urology Oncology;2024-02

2. Clinical advancement of precision theranostics in prostate cancer;Frontiers in Oncology;2023-02-02

3. Complementary Role of 18F-Fluciclovine PET/CT and 18F-NaF PET/CT in Detecting Prostate Cancer Metastasis;Clinical Nuclear Medicine;2023-01-31

4. Prostate Cancer Imaging with 18F-Fluciclovine;PET Clinics;2022-10

5. Diagnostic Applications of Nuclear Medicine: Prostatic Cancer;Nuclear Oncology;2022